Oragenics's total assets for Q were $5.20M, an increase of 92.05% from the previous quarter. OGEN total liabilities were $2.13M for the fiscal quarter, a 53.73% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.